Book contents
- Cambridge Textbook Of Neuroscience for Psychiatrists
- Reviews
- Cambridge Textbook of Neuroscience for Psychiatrists
- Copyright page
- Contents
- Contributors
- Introduction
- 1 Cells
- 2 Neurotransmitters and Receptors
- 3 Basic Techniques in Neuroscience
- 4 Neuroanatomy
- 5 Neural Circuits
- 6 Modulators
- 6.1 The Hypothalamic–Pituitary (Neuroendocrine) Axis
- 6.2 The Stress Response and Glucocorticoids
- 6.3 Adrenal Steroids
- 6.4 Inflammation and Immune Responses
- 7 Genetics
- 8 Neurodevelopment and Neuroplasticity
- 9 Integrated Neurobiology of Specific Syndromes and Treatments
- 10 Neurodegeneration
- Index
- References
6.3 - Adrenal Steroids
from 6 - Modulators
Published online by Cambridge University Press: 08 November 2023
Book contents
- Cambridge Textbook Of Neuroscience for Psychiatrists
- Reviews
- Cambridge Textbook of Neuroscience for Psychiatrists
- Copyright page
- Contents
- Contributors
- Introduction
- 1 Cells
- 2 Neurotransmitters and Receptors
- 3 Basic Techniques in Neuroscience
- 4 Neuroanatomy
- 5 Neural Circuits
- 6 Modulators
- 6.1 The Hypothalamic–Pituitary (Neuroendocrine) Axis
- 6.2 The Stress Response and Glucocorticoids
- 6.3 Adrenal Steroids
- 6.4 Inflammation and Immune Responses
- 7 Genetics
- 8 Neurodevelopment and Neuroplasticity
- 9 Integrated Neurobiology of Specific Syndromes and Treatments
- 10 Neurodegeneration
- Index
- References
Summary
This chapter focuses on the observations that variations in adrenal steroid levels, particularly cortisol, contribute to psychopathology and major depression in particular. The associations are complex due to clinical heterogeneity together with physiological and genetic variations, influencing corticoid production, function and activation by environmental adversities. There is evidence that genetic differences in adrenal function, the impact of chronic early adversity, excess corticoid production or exogenous corticoids each contribute to the risk of depression, delay in clinical recovery and relapse. Further, psychiatric illnesses, mainly but not exclusively depression, may induce changes in corticoid activity. Elevated corticoids can affect psychological function, in particular reduced memory acuity for recall of and emotional responses to life experiences.
- Type
- Chapter
- Information
- Cambridge Textbook of Neuroscience for Psychiatrists , pp. 307 - 315Publisher: Cambridge University PressPrint publication year: 2023
References
Askelund, AD, Schweizer, S, Goodyer, IM, van Harmelen, AL (2019). Positive memory specificity is associated with reduced vulnerability to depression. Nat Hum Behav 3(3): 265–273.CrossRefGoogle ScholarPubMed
Deuschle, M, Schweiger, U, Weber, B et al. (1997). Diurnal activity and pulsatility of the hypothalamus-pituitary-adrenal system in male depressed patients and healthy controls. J Clin Endocrinol Metab 82: 234–238.CrossRefGoogle ScholarPubMed
Fischer, S, Strawbridge, R, Vives, AH, Cleare, AJ (2017). Cortisol as a predictor of psychological therapy response in depressive disorders: systematic review and meta-analysis. Br J Psychiatry 210(2): 105–109.CrossRefGoogle ScholarPubMed
Goodyer, IM, Wilkinson, PO. (2019). Practitioner review: therapeutics of unipolar major depressions in adolescents. J Child Psychol Psychiatry; 60(3): 232–243.CrossRefGoogle ScholarPubMed
Goodyer, IM, Croudace, T, Dudbridge, F, Ban, M, Herbert, J (2010). Polymorphisms in BDNF (Val66Met) and 5-HTTLPR, morning cortisol and subsequent depression in at-risk adolescents. Br J Psychiatry 197(5): 365–371.CrossRefGoogle ScholarPubMed
Goodyer, IM, Reynolds, S, Barrett, B et al. (2017). Cognitive behavioural therapy and short-term psychoanalytical psychotherapy versus a brief psychosocial intervention in adolescents with unipolar major depressive disorder (IMPACT): a multicentre, pragmatic, observer-blind, randomised controlled superiority trial. Lancet Psychiatry 4(2): 109–119.CrossRefGoogle ScholarPubMed
Herbert, J (2013). Cortisol and depression: three questions for psychiatry. Psychol Med 43(3): 449–69.CrossRefGoogle ScholarPubMed
Howard, DM, Adams, MJ, Clarke, TK et al. (2019). Genome-wide meta-analysis of depression identifies 102 independent variants and highlights the importance of the prefrontal brain regions. Nat Neurosci 22(3): 343–352.CrossRefGoogle ScholarPubMed
Ising, M, Maccarrone, G, Brückl, T et al. (2019). FKBP5 gene expression predicts antidepressant treatment outcome in depression. Int J Mol Sci 20(3): 485.CrossRefGoogle ScholarPubMed
McAllister-Williams, RH, Smith, E, Anderson, IM (2013). Study protocol for the randomised controlled trial: antiglucocorticoid augmentation of anti-depressants in depression (the ADD study). BMC Psychiatry 13: 205.CrossRefGoogle ScholarPubMed
Owens, M, Herbert, J, Jones, PB et al. (2014). Elevated morning cortisol is a stratified population-level biomarker for major depression in boys only with high depressive symptoms. Proc Natl Acad Sci USA 111(9): 3638–3643.CrossRefGoogle ScholarPubMed
Pariante, CM (2017). Why are depressed patients inflamed? A reflection on 20 years of research on depression, glucocorticoid resistance and inflammation. Eur Neuropsychopharmacol 27(6): 554–559.CrossRefGoogle ScholarPubMed
Rao, S, Yao, Y, Ryan, J et al. (2016). Common variants in FKBP5 gene and major depressive disorder (MDD) susceptibility: a comprehensive meta-analysis. Sci Rep 6: 32687.CrossRefGoogle ScholarPubMed